Hospital Pharmacy Europe

JANUARY 16, 2025

A new global study from the International Pharmaceutical Federation (FIP)s Pediatric Formulations Focus Group is the first to report current and global paediatric oral extemporaneous compounding practices. The FIP study aimed to identify current global paediatric oral extemporaneous compounding practices, challenges and needs.

Compounding 119

Compounding Labelling Dosage Hospitals 119

ISPE

OCTOBER 26, 2022

From a regulatory perspective, the only products that are to be excluded are sensitizing agents, including penicillins and cephalosporins (beta-lactams); potentially genotoxic compounds; and potentially OEB 5 compounds where the risk assessment indicates the compound cannot be adequately controlled. Published 2003.

Vaccines 97

Vaccines Compounding Documentation FDA 97

ISPE

NOVEMBER 2, 2022

As a result, I was asked to present learning points and outcomes of that inspection at a GAMP Forum in San Francisco in January 2003. New CoPs are being established, including compounding and quality. will continue to expand the Society’s global engagement, he said.

Documentation 52

Documentation Compounding Communication FDA 52

ISPE

MAY 9, 2023

Additionally, quality control testing of these compounds is conducted using standard testing following applicable pharmacopeia—such as United States Pharmacopeia (USP), European Pharmacopeia (EP), and Japanese Pharmacopeia (JP)—that was current at the time of testing. “ICH Published February 2003. Published February 2003.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52